Advent Life Sciences

VC · London (United Kingdom)

VC

Seed

Series A

Hardware

Healthcare

Sign up free to access full profile and submit your pitch.

About

Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and inve stment success through turning break-through science into approved medicines or medical products. We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines.

Investment Criteria

Other investors that have backed the same portfolio companies as Advent Life Sciences. Expand any entry to see the shared portfolio companies.

• Columbus Venture Partners, S.G.E.I.C., S.A.U

  5 shared

  Shared portfolio companies

  • Aleta Biotherapeutics, Inc.
  • Artax Biopharma, Inc.
  • Curve Therapeutics Limited
  • Highlight Therapeutics, S.L.
  • NeRRe Therapeutics Ltd.
• Gilde Healthcare Partners B.V.

  5 shared

  Shared portfolio companies

  • Amphista Therapeutics Limited
  • Argá Medtech SA
  • Levicept Ltd.
  • Moximed, Inc.
  • Nalu Medical, Inc.
• Novo Holdings

  5 shared

  Shared portfolio companies

  • F2G Ltd
  • Glycomine, Inc.
  • Nalu Medical, Inc.
  • NeRRe Therapeutics Ltd.
  • Rappta Therapeutics Oy
• Forbion

  4 shared

  Shared portfolio companies

  • Amphista Therapeutics Limited
  • Beacon Therapeutics Limited
  • F2G Ltd
  • NeRRe Therapeutics Ltd.
• EQT Holdings AB

  3 shared

  Shared portfolio companies

  • AviadoBio Ltd
  • Cyted Ltd
  • Eloxx Pharmaceuticals, Inc.
• Medicxi Ventures (UK) LLP

  3 shared

  Shared portfolio companies

  • Aravive, Inc.
  • Aura Biosciences, Inc.
  • Levicept Ltd.
• New Enterprise Associates

  3 shared

  Shared portfolio companies

  • AviadoBio Ltd
  • Infinity Pharmaceuticals, Inc.
  • Moximed, Inc.
• Novartis Venture Fund

  3 shared

  Shared portfolio companies

  • Amphista Therapeutics Limited
  • F2G Ltd
  • Rappta Therapeutics Oy
• Canaan Partners

  2 shared

  Shared portfolio companies

  • Arrakis Therapeutics, Inc.
  • Iterum Therapeutics plc
• Chiesi Ventures

  2 shared

  Shared portfolio companies

  • Aura Biosciences, Inc.
  • Glycomine, Inc.